Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Motta

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
ACS Chemical Neuroscience|September 23, 2021
Se-[(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl] 4-Chlorobenzoselenolate Attenuates Inflammatory Response, Nociception, and Affective Disorders Related to Rheumatoid Arthritis in MiceEthel A Wilhelm, Paola S Soares, Angélica S Reis, et al.
Journal of Neurosurgical Sciences|March 26, 2026
Safety and efficacy of the Neuroform Atlas stent in the treatment of intracranial arterial stenosis: a systematic review and single-arm meta-analysisIago N Simom Petry, Kaike Lobo, Yasmin P Silva, et al.
Pharmacological Reports : PR|November 1, 2019
Se - [(2,2-Dimethyl-1,3-dioxolan-4-yl) methyl] 4-chlorobenzoselenolate reduces the nociceptive and edematogenic response by chemical noxious stimuli in mice: Implications of multi-target actionsEthel A Wilhelm, Paola S Soares, Angélica S Reis, et al.
Immunologic Research|June 4, 2024
Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter studyRenan A Pereira, Ellen O Dantas, Jessica Loekmanwidjaja, et al.
Orphanet Journal of Rare Diseases|July 2, 2025
Nutritional status and metabolic alterations in patients with ataxia-telangiectasiaCristiano do Amaral de Leon, Sérgio Luis Amantea, Renan Augusto Pereira, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
ACS Chemical Neuroscience|September 23, 2021
Se-[(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl] 4-Chlorobenzoselenolate Attenuates Inflammatory Response, Nociception, and Affective Disorders Related to Rheumatoid Arthritis in MiceEthel A Wilhelm, Paola S Soares, Angélica S Reis, et al.
Journal of Neurosurgical Sciences|March 26, 2026
Safety and efficacy of the Neuroform Atlas stent in the treatment of intracranial arterial stenosis: a systematic review and single-arm meta-analysisIago N Simom Petry, Kaike Lobo, Yasmin P Silva, et al.
Pharmacological Reports : PR|November 1, 2019
Se - [(2,2-Dimethyl-1,3-dioxolan-4-yl) methyl] 4-chlorobenzoselenolate reduces the nociceptive and edematogenic response by chemical noxious stimuli in mice: Implications of multi-target actionsEthel A Wilhelm, Paola S Soares, Angélica S Reis, et al.
Immunologic Research|June 4, 2024
Ataxia-telangiectasia in Latin America: clinical features, immunodeficiency, and mortality in a multicenter studyRenan A Pereira, Ellen O Dantas, Jessica Loekmanwidjaja, et al.
Orphanet Journal of Rare Diseases|July 2, 2025
Nutritional status and metabolic alterations in patients with ataxia-telangiectasiaCristiano do Amaral de Leon, Sérgio Luis Amantea, Renan Augusto Pereira, et al.
Pageof 6